Related Experiment Videos

Factors influencing the publication of randomized controlled trials in child health research

Lisa Hartling1, William R Craig, Kelly Russell

  • 1Alberta Research Centre for Child Health Evidence, Department of Pediatrics, University of Alberta, Edmonton, Canada. lisa.hartling@ualberta.ca

Insights

Many pediatric research abstracts are not published, often due to lack of time or perceived low scientific merit. Most unpublished studies were never submitted, highlighting a significant publication bias issue.

Area of Science:

  • Pediatric Research
  • Clinical Trials
  • Publication Ethics

Background:

  • Publication bias can undermine clinical decisions.
  • Root causes of publication bias are poorly understood, especially in child research.
  • Limited investigation exists regarding publication bias in pediatric research literature.

Purpose of the Study:

  • Identify factors linked to nonpublication of presented abstracts.
  • Determine the relative importance of reasons for nonpublication.
  • Investigate publication bias in pediatric research.

Main Methods:

  • Cross-sectional survey of researchers presenting randomized controlled trials (RCTs) at Society for Pediatric Research meetings (1992-1995).
  • Utilized a modified Total Design Method for mail surveys with multiple follow-ups.
  • Analyzed factors associated with selective publication of RCTs.

Main Results:

  • 72% of abstracts were published as full manuscripts.
  • Nonpublication was associated with perceived lower scientific merit and significance of results.
  • Of unpublished studies, 83% were never submitted for publication.

Conclusions:

  • The majority of unpublished RCTs were never submitted for publication.
  • Lack of time was the most frequently cited reason for nonpublication.
  • Addressing barriers to submission is crucial to mitigate publication bias in pediatric research.
Abstract

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Randomized Experiments01:13

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...